[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362819-105":59,"doc-detail-362819-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrative-pan-cancer-analysis-of-dipeptidyl-peptidase-4-with-clinical-and-in-vitro-validation-in-prostate-cancer","Integrative pan-cancer analysis of dipeptidyl peptidase 4 with clinical and in vitro validation in prostate cancer","","Dipeptidyl peptidase 4 (DPP4) is known for broad physiological roles, yet its pan-cancer impact and immune-modulatory functions remain unclear. This study integrates transcriptomic, genomic, and immunogenomic analyses to evaluate DPP4 across cancer types, including differential expression, ceRNA networks, protein interactions, immune infiltration, drug sensitivity, and molecular docking/dynamics. Single-cell and validation analyses support DPP4’s role in prostate cancer, with clinical cohort immunohistochemistry and survival associations, plus qPCR experiments under drug treatments.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrative-pan-cancer-analysis-of-dipeptidyl-peptidase-4-with-clinical-and-in-vitro-validation-in-prostate-cancer/362819/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrative-pan-cancer-analysis-of-dipeptidyl-peptidase-4-with-clinical-and-in-vitro-validation-in-prostate-cancer/362819.png","ImageObject",300,407,{"name":92,"@type":93},"Fahsai","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the goal of the integrative study on DPP4?","Question",{"text":112,"@type":113},"To determine the pan-cancer significance of DPP4 and validate its role in prostate cancer using multi-omics analyses and clinical plus in vitro experiments.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which analytical approaches were used to evaluate DPP4 across cancers?",{"text":117,"@type":113},"The study assessed differential expression, ceRNA networks, protein interactions, immune infiltration, drug sensitivity, molecular docking, and molecular dynamics, and also performed single-cell, virtual knockout, and TIDE analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about DPP4 in prostate cancer and patient outcomes?",{"text":121,"@type":113},"In prostate cancer, DPP4 was markedly downregulated, while higher DPP4 expression predicted better overall survival and progression-free survival, with significant associations involving Gleason score and WHO/ISUP grade.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362819,1790262834,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","TYPE Original Research PUBLISHED 12 March 2026  \nDOI 10.3389/fimmu.2026.1616889  \nOPEN ACCESS  \nEDITED BY  \nZong Sheng Guo,  \nUniversity at Buffalo, United States  \nREVIEWED BY  \nJiachen Ge,  \nHenan Provincial People’s Hospital, China Guangyu Zhao,  \nAcademy of Military Medical Science, China  \n*CORRESPONDENCE  \nXiuwu Pan  \n [panxiuwu@126.com](panxiuwu@126.com)[ ](panxiuwu@126.com)Ping Huang  \n [lyq2001@vip.sina.com](lyq2001@vip.sina.com)[ ](lyq2001@vip.sina.com)Yifan Liu  \n [lyf0501@sjtu.edu.cn](lyf0501@sjtu.edu.cn)[ ](lyf0501@sjtu.edu.cn)Yuntao Yao  \n[1604239807@qq.com](1604239807@qq.com)[ ](1604239807@qq.com)†These authors have contributed equally to this work  \nRECEIVED 23 April 2025  \nREVISED 21 February 2026  \nACCEPTED 23 February 2026  \nPUBLISHED 12 March 2026  \nCITATION  \nLi Y, Lu B, Zhao Z, Gong M, Lyu D, Zhang H, Huang R, Yao Y, Liu Y, Huang P and Pan X (2026) Integrative pan-cancer analysis of dipeptidylpeptidase 4 with clinical and in vitro validation in prostate cancer.  \nFront. Immunol. 17:1616889 .  \ndoi: 10.3389/fimmu.2026.1616889  \nCOPYRIGHT  \n© 2026 Li, Lu, Zhao, Gong, Lyu, Zhang, Huang, Yao, Liu, Huang and Pan. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nIntegrative pan-cancer analysis of dipeptidyl peptidase 4 with clinical and in vitro validation in prostate cancer  \nYuanan Li 1†, Bingnan Lu 1†, Zihui Zhao 1†, Ming Gong 2†, Donghao Lyu 1, Haoyu Zhang 1, Runzhi Huang 3, Yuntao Yao 1*, Yifan Liu 1*, Ping Huang 1* and Xiuwu Pan 1*  \n1 Department of Urology, Xinhua Hospital Afﬁliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China, 2 Department of Urology, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China, 3 Department of Burn Surgery, The First Afﬁliated Hospital of Naval Medical University, Shanghai, China  \nBackground: Dipeptidyl peptidase 4 (DPP4) plays diverse physiological roles, but its pan-cancer signiﬁcance and immuno modulatory functions remain poorly characterized.  \nMethods: We performed an integrative pan-cancer analysis of DPP4, incorporating transcriptomic, genomic, and immunogenomic approaches. Differential expression, ceRNA networks, protein interactions, immune inﬁltration, drug sensitivity, molecular docking, and molecular dynamics were systematically evaluated. Single-cell sequencing analysis, virtual knockout analysis and TIDE analysis were conducted to validate the role of DPP4 in prostate cancer. Further clinical validation was conducted in a prostate cancer cohort (n=97) using immunohistochemistry, Kaplan-Meier survival analysis, and clinicopathological correlation studies were also conducted. DPP4 expression was assessed by qPCR in 22Rv1 and C4–2 cells treated with dasatinib or midostaurin at IC50 concentrations.  \nResults: DPP4 exhibited tumor-speciﬁc dysregulation across multiple cancer types. Its expression correlated signiﬁcantly with patient prognosis, tumor stage, genomic alterations, immune cell composition, and therapeutic response. In prostate cancer, DPP4 was markedly downregulated (p \u003C 0 . 001) and higher expression predicted better overall survival (p \u003C 0 . 001) and progression-free survival (p \u003C 0 . 001) . Signiﬁcant associations were observed with Gleason score (p = 0 . 03) and WHO/ISUP grade (p = 0 . 03) . After dasatinib treatment, DPP4 expression in C4–2 was signiﬁcantly elevated (p \u003C 0 . 001) . On the contrary, DPP4 expression in both 22Rv1 and C4–2 was reduced after treatment with midostarin (p \u003C 0 . 05) .  \nConclusion: Our study establishes DPP4 as a multifaceted pan-cancer biomarker with prognostic","cbCaihCXprHWANrQ","https://ap.wps.com/l/cbCaihCXprHWANrQ","pdf",10811813,23,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Key words","[{\"question\":\"What was the goal of the integrative study on DPP4?\",\"answer\":\"To determine the pan-cancer significance of DPP4 and validate its role in prostate cancer using multi-omics analyses and clinical plus in vitro experiments.\"},{\"question\":\"Which analytical approaches were used to evaluate DPP4 across cancers?\",\"answer\":\"The study assessed differential expression, ceRNA networks, protein interactions, immune infiltration, drug sensitivity, molecular docking, and molecular dynamics, and also performed single-cell, virtual knockout, and TIDE analyses.\"},{\"question\":\"What did the study find about DPP4 in prostate cancer and patient outcomes?\",\"answer\":\"In prostate cancer, DPP4 was markedly downregulated, while higher DPP4 expression predicted better overall survival and progression-free survival, with significant associations involving Gleason score and WHO/ISUP grade.\"}]","Integrative pan-cancer analysis of dipeptidyl peptidase 4 with clinical and in vitro validation in prostate cancer | PDF",1790149142,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/515899bccc036f6fe5388b43760cbbb4.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48235bd96731a2ed22f3ccac7bdb7bf1.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/debb19f9886487dbd8e25c08173fe181.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a543881e4c02132c3a75e353a8047965.webp",980,1385]